As results of the first human trials of Oxford University vaccine show immune reaction produced without any serious adverse reactions, virologist Dr Elisabetta Groppelli joins Theodora Louloudis to discuss why she thinks the results are ‘very, very encouraging’, whether a vaccine is ‘one size fits all’ and how virus mutation could affect crucial immunology research.

Read more about the potential coronavirus treatment from Synairgen: https://bit.ly/2WG5Fzr

Read more about Test and Trace privacy allegations: https://bit.ly/2WEPdPS

Read more about French face masks: https://bit.ly/3fMPSq6

For 30 days' free access to The Telegraph: www.telegraph.co.uk/audio

Email: coronaviruspodcast@telegraph.co.uk

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hosted on Acast. See acast.com/privacy for more information.